Anticipating a COVID Vaccine: Considerations for Employers and Consumer Facing Businesses
Webinar | 09.21.20, 7:00 AM EDT - 8:00 AM EDT
A COVID-19 vaccine may be ready for distribution in the United States by the end of the year. Polls show that a significant percentage of Americans are reluctant to get vaccinated, at least initially, and public health officials are recommending a cautious approach to the issue. U.S. businesses will have to resolve important and potentially controversial questions once vaccines become available, including the issue of whether companies should require vaccinations of their employees and/or customers. News reports also suggest that vaccination may be required by federal and/or state governments, which would be an unprecedented mandate leading to additional compliance questions and potential liability concerns for businesses.
During this webinar, a special edition of our Third Thursday webinar series, we will discuss the current status of vaccine development in the context of the FDA’s emergency use authorization process, as well as lessons learned from other mandatory vaccination programs in schools and in the healthcare sector. Our panel will also discuss liability issues focusing on anticipated litigation trends concerning the evolving standard of care in COVID-19 exposure litigation, and important employment law questions businesses will have to address in deciding on a course of action to minimize legal and reputational risk.
For more information, please visit these areas: Labor and Employment, Mass Tort, Product, and Consumer Litigation
Contact
Participants
Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 09.29.25
False Claims Act and Customs Enforcement—What You Need to Know
Webinar | 09.25.25